Clinicopathologic Correlations of Jaw Tremor in a Longitudinal Aging Study
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received July 21, 2021
- Accepted July 19, 2022
- First Published September 9, 2022.
Article Versions
- Previous version (September 9, 2022 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Sana Aslam, DO,
- Nan Zhang, PhD,
- Charles H. Adler, MD, PhD,
- Thomas G. Beach, MD, PhD,
- Erika Driver-Dunckley, MD,
- Shyamal H. Mehta, MD, PhD and
- Holly Shill, MD
- Sana Aslam, DO,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Nan Zhang, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Charles H. Adler, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
Acorda, Amneal, Axovant, Cionic, Eisai, Jazz, Neurocrin
NONE
NONE
NONE
NONE
NIH/NINDS, 1U01NS093334-01, investigator, 2015-Present
NONE
Michael J. Fox Foundation for Parkinson's Disease <br>Research
NONE
NONE
NONE
NONE
Cionic, 2020-2022
NONE
- Thomas G. Beach, MD, PhD,
1) Scientific advisory board for Vivid Genomics
NONE
1) Speaker honorarium from World Parkinson Coalition
1) Editorial board, Journal of Alzheimer's Disease<br>2) Editorial board, Journal of Neuropathology and Experimental <br>Neurology
NONE
NONE
I have been employed since 1997 solely with the non-<br>profit organizations Sun Health Research Institute and <br>Banner Health.
1) Vivid Genomics <br>2) Acadia Pharmaceuticals
NONE
NONE
NONE
1) Avid Radiopharmaceuticals
1) National Institute on Aging P30 AG19610, Co-Investigator, <br>2001 - present<br>2) National Institute of Neurological Disorders and Stroke, <br>R01 NS118669, 2021 - present
NONE
1) Michael J. Fox Foundation for Parkinson’s Research<br>2) Sun Health Foundation
1) Vivid Genomics, Inc, stock option
NONE
NONE
Vivid Genomics
Vivid Genomics
NONE
- Erika Driver-Dunckley, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Shyamal H. Mehta, MD, PhD and
Attended Advisory Board Meeting:<br>1) AbbVie <br>2) Abbott Inc<br>3) Adamas Pharmaceuticals
NONE
None
NONE
NONE
NONE
NONE
1) AbbVie <br>2) Abbott<br>3) Adamas Pharmaceuticals
NONE
NONE
NONE
1) AbbVie <br>2) Abbott<br>3) Adamas Pharmaceuticals
Arizona Biomedical Research Consortium
NONE
International Essential Tremor Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Holly Shill, MD
None
NONE
None
NONE
NONE
NONE
NONE
Abbvie, Biogen, Amneal, Acorda, Neurocrine
NONE
NONE
NONE
Dr. Shill has research support from Transposon, Saccadous, US <br>World Meds/Supernus, Cavion, Cerevel, Impax.
NINDS/NIH. NN110: A Dose Selection Trial of Light Therapy <br>for Impaired Sleep in Parkinson’s Disease. Oct. 2020-<br>present. Role: Local PI.<br>NINDS/NIH. Network for Excellence in Neuroscience <br>Clinical Trials (NeuroNEXT). 9/2018-present. Role: Co-PI. <br>10% FTE.
NONE
Michael J Fox Foundation for Parkinson Research<br>Barrow Neurological Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Department of Neurology (SA, HS), Barrow Neurological Institute, Phoenix, AZ; Department of Neurology (NZ, CHA, ED-D, SHM), Mayo Clinic, Scottsdale, AZ; and Banner Sun Health Research Institute (TGB), Sun City, AZ.
- Correspondence
Dr. Aslam sana.aslam{at}barrowneuro.org
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.